Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

Blocking mTORC1 reduces skin tumor growth in mice.

Homozygous K5Cre transgenic mice have wavy hair and faster cancer progression.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

Oncogenic melanocyte stem cells can develop into melanoma similar to human cases.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

HPV8 causes skin cancer by expanding specific skin stem cells.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.